KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Liabilities and Shareholders Equity (2016 - 2026)

Chemed filings provide 18 years of Liabilities and Shareholders Equity readings, the most recent being $1.5 billion for Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 11.05% year-over-year to $1.5 billion, compared with a TTM value of $6.4 billion through Mar 2026, down 7.02%, and an annual FY2025 reading of $1.5 billion, down 7.81% over the prior year.
  • Liabilities and Shareholders Equity hit $1.5 billion in Q1 2026 for Chemed, roughly flat from $1.5 billion in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $1.8 billion in Q3 2024, with the low at $1.3 billion in Q1 2022.
  • Median Liabilities and Shareholders Equity over the past 5 years was $1.6 billion (2023), compared with a mean of $1.6 billion.
  • The sharpest move saw Liabilities and Shareholders Equity increased 20.71% in 2024, then dropped 11.05% in 2026.
  • Year by year, Liabilities and Shareholders Equity stood at $1.4 billion in 2022, then rose by 15.68% to $1.7 billion in 2023, then increased by 0.03% to $1.7 billion in 2024, then decreased by 7.81% to $1.5 billion in 2025, then fell by 0.15% to $1.5 billion in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $1.5 billion, $1.5 billion, and $1.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.